Real-life treatment of cholinergic urticaria with omalizumab.

[1]  T. Jakob,et al.  Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence , 2017, The Journal of allergy and clinical immunology.

[2]  T. Horikawa,et al.  Cholinergic urticaria: epidemiology, physiopathology, new categorization, and management , 2018, Clinical Autonomic Research.

[3]  M. Maurer,et al.  Increased IgE levels are linked to faster relapse in patients with omalizumab-discontinued chronic spontaneous urticaria. , 2017, The Journal of allergy and clinical immunology.

[4]  M. Gonçalo,et al.  Long‐term management of chronic spontaneous urticaria with omalizumab , 2017, Clinical and experimental dermatology.

[5]  M. Maurer,et al.  Cholinergic urticaria patients of different age groups have distinct features , 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[6]  Janko Brand,et al.  Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria. , 2017, The Journal of allergy and clinical immunology.

[7]  S. Thomsen,et al.  Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients , 2016, The British journal of dermatology.

[8]  M. Magerl,et al.  An improved Peltier effect‐based instrument for critical temperature threshold measurement in cold‐ and heat‐induced urticaria , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[9]  N. Kohno,et al.  Elevated serum IgE against MGL_1304 in patients with atopic dermatitis and cholinergic urticaria. , 2014, Allergology international : official journal of the Japanese Society of Allergology.

[10]  M. Maurer,et al.  Development of a standardized pulse-controlled ergometry test for diagnosing and investigating cholinergic urticaria. , 2014, Journal of dermatological science.

[11]  M. Maurer,et al.  Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis. , 2014, Journal of dermatological science.

[12]  S. Mathur,et al.  Retrospective analysis of the efficacy of omalizumab in chronic refractory urticaria , 2013, Allergy and asthma proceedings.

[13]  T. Zuberbier,et al.  Anti-Immunoglobulin E Treatment of Patients with Recalcitrant Physical Urticaria , 2010, International Archives of Allergy and Immunology.

[14]  T. Zuberbier,et al.  Successful treatment of solar urticaria with anti‐immunoglobulin E therapy , 2008, Allergy.

[15]  T. Zuberbier,et al.  Successful treatment of cholinergic urticaria with anti‐immunoglobulin E therapy , 2008, Allergy.

[16]  A. Levinson,et al.  Evaluation of a patient with cold and cholinergic urticaria. , 1979, The Journal of allergy and clinical immunology.